Infimer (Israel) Buy Hold or Sell Recommendation
| INFR Stock | ILA 20,890 15,890 317.80% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Infimer is 'Cautious Hold'. Macroaxis provides Infimer buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Infimer positions.
Check out Infimer Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Infimer and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Infimer. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Infimer |
Execute Infimer Buy or Sell Advice
The Infimer recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Infimer. Macroaxis does not own or have any residual interests in Infimer or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Infimer's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Strong | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Infimer Trading Alerts and Improvement Suggestions
| Infimer is way too risky over 90 days horizon | |
| Infimer appears to be risky and price may revert if volatility continues | |
| Infimer has accumulated 289 K in total debt. Infimer has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Infimer until it has trouble settling it off, either with new capital or with free cash flow. So, Infimer's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Infimer sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Infimer to invest in growth at high rates of return. When we think about Infimer's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 378 K. Net Loss for the year was (7.99 M) with loss before overhead, payroll, taxes, and interest of (899 K). | |
| Infimer has accumulated about 14 K in cash with (1.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 14.0% of the company shares are held by company insiders |
Infimer Returns Distribution Density
The distribution of Infimer's historical returns is an attempt to chart the uncertainty of Infimer's future price movements. The chart of the probability distribution of Infimer daily returns describes the distribution of returns around its average expected value. We use Infimer price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Infimer returns is essential to provide solid investment advice for Infimer.
| Mean Return | 69,199 | Value At Risk | -99.97 | Potential Upside | 340,567 | Standard Deviation | 2,089,000 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Infimer historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Infimer Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Infimer or Chemicals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Infimer's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Infimer stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 69,191 | |
β | Beta against Dow Jones | 95.00 | |
σ | Overall volatility | 343.92 | |
Ir | Information ratio | 0.21 |
Infimer Volatility Alert
Infimer is showing large volatility of returns over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Infimer's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Infimer's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Infimer Fundamentals Vs Peers
Comparing Infimer's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Infimer's direct or indirect competition across all of the common fundamentals between Infimer and the related equities. This way, we can detect undervalued stocks with similar characteristics as Infimer or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Infimer's fundamental indicators could also be used in its relative valuation, which is a method of valuing Infimer by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Infimer to competition |
| Fundamentals | Infimer | Peer Average |
| Return On Asset | -0.33 | -0.14 |
| Operating Margin | (9.80) % | (5.51) % |
| Current Valuation | 25.15 M | 16.62 B |
| Shares Outstanding | 1.06 M | 571.82 M |
| Shares Owned By Insiders | 14.32 % | 10.09 % |
| Shares Owned By Institutions | 10.35 % | 39.21 % |
| Price To Earning | (867.76) X | 28.72 X |
| Price To Sales | 4,759 X | 11.42 X |
| Revenue | 378 K | 9.43 B |
| Gross Profit | (899 K) | 27.38 B |
| EBITDA | (3.15 M) | 3.9 B |
| Net Income | (7.99 M) | 570.98 M |
| Cash And Equivalents | 14 K | 2.7 B |
| Cash Per Share | 0.01 X | 5.01 X |
| Total Debt | 289 K | 5.32 B |
| Current Ratio | 0.02 X | 2.16 X |
| Book Value Per Share | (5.82) X | 1.93 K |
| Cash Flow From Operations | (1.59 M) | 971.22 M |
| Earnings Per Share | (5.30) X | 3.12 X |
| Number Of Employees | 23.7 K | 18.84 K |
| Beta | 1.52 | -0.15 |
| Market Capitalization | 17.99 M | 19.03 B |
| Z Score | 37.2 | 8.72 |
| Last Dividend Paid | 589.96 |
Infimer Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Infimer . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 1.0 | |||
| Daily Balance Of Power | 0.7612 | |||
| Rate Of Daily Change | 4.18 | |||
| Day Median Price | 10452.0 | |||
| Day Typical Price | 13931.33 | |||
| Market Facilitation Index | 20876.0 | |||
| Price Action Indicator | 18383.0 | |||
| Period Momentum Indicator | 15890.0 |
About Infimer Buy or Sell Advice
When is the right time to buy or sell Infimer? Buying financial instruments such as Infimer Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Infimer in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Moderate Funds Thematic Idea Now
Moderate Funds
Funds or Etfs that combine stocks, bonds and money market instruments to get modest capital appreciation over time. The Moderate Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Moderate Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Infimer Stock
Infimer financial ratios help investors to determine whether Infimer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Infimer with respect to the benefits of owning Infimer security.